Veterinary Pharmaceutical Manufacturing in Australia - Market Research Report (2014-2029)
Melbourne, Australia
Last Updated: June 2024
ANZSIC C1842Revenue
$1.0bn
Past 5-Year Growth
Profit
$XXX.Xm
Employees
1,530
Businesses
98
Wages
$XXX.Xm
Veterinary Pharmaceutical Manufacturing in Australia industry analysis
Veterinary pharmaceutical manufacturers have endured their fair share of challenging trading conditions. Demand from downstream beef, cattle and sheep farming has been volatile thanks to seasonal weather patterns that battered farmers with either prolonged drought conditions or escalating flood waters. Livestock numbers fell in the face of these extreme conditions and, with it tumbled demand for veterinary pharmaceuticals. Stringent regulatory controls, higher compliance costs and growing consolidation pressures have compounded this issue, prompting several major global pharmaceutical companies to divest their animal health pharmaceutical operations.
Trends and Insights
- Seasonal weather conditions have weakened demand from livestock farmers. Yet, a surge in pet ownership and pet humanisation trends has supported an upswing in revenue.
- Parasiticides are the largest product segment for veterinary pharmaceutical manufacturers. Yet, sales have slid thanks to a rigorous approval process and strong regulations.
- New South Wales, Victoria and Queensland dominate the veterinary pharmaceutical market based on the location of manufacturers. Access to shipping ports, airports and chemical suppliers combine to sway company location.
- Economies of scale are a competitive advantage for veterinary pharmaceutical manufacturers. Being able to spread fixed and variable costs over a larger product base provides cost advantages for larger manufacturers.
Industry Overview
Market size and recent performance (2014-2029)
Industry revenue has grown at a CAGR of 1.5 % over the past five years, to reach an estimated $1.0bn in 2024.
Trends and Insights
Demand from livestock farmers has been volatile
- Livestock farming has been at the mercy of seasonal weather patterns in recent years, with annual fluctuations in weather conditions having a direct bearing on herd numbers and downstream demand for veterinary pharmaceuticals.
- Additional trends and insights available with purchase
Source: IBISWorld
Industry outlook (2024-2029)
Market size is projected to grow over the next five years.
Trends and Insights
Ongoing shifts towards pet humanisation to drive demand
- Pet owners are set to progressively view their animal companions as part of the extended family meaning. Shifts towards pet humanisation mean pet owners will choose to spend money on the health and well-being of their pets, fuelling demand for preventative medicines to boost the lifespan of companion animals.
Biggest companies in the Veterinary Pharmaceutical Manufacturing in Australia
| Company | Market Share (%)
2024 | Revenue ($m)
2024 |
|---|---|---|
Zoetis Australia | 540.0 | |
MSD Animal Health | 230.0 | |
Virbac (Australia) | 210.0 |
To view the market share and analysis for all 5 top companies in this industry, view purchase options.
Products & Services Segmentation
Source: IBISWorld
Industry revenue is measured across several distinct product and services lines, including Parasiticides, Other products and Antibiotics and related products. Parasiticides is the largest segment of the Veterinary Pharmaceutical Manufacturing in Australia.
Trends and Insights
Sales of parasiticides have slid owing to strict usage restrictions
- Parasiticides are veterinary products that kill both internal and external parasites and are essential for animal health. Endoparasiticide products treat internal parasites, while endectocides treat both external and internal parasites.
- More insights available in the full report
Widen you competitive advantage with related industries
Competitors
- Pharmaceutical Product Manufacturing in Australia
- Pesticide Manufacturing in Australia
Complementors
- Livestock and Other Agricultural Supplies Wholesaling in Australia
- Veterinary Services in Australia
International industries
- Animal Health Biotechnology in the US
- Veterinary Pharmaceutical and Medicinal Product Manufacturing in New Zealand
- Pharmaceutical Preparations Manufacturing in the UK
- Pharmaceutical Preparations Manufacturing in Ireland
Table of Contents
About this industry
Industry definition
Industry firms manufacture drugs, medicines, medicinal chemicals, vaccines, serums and other pharmaceutical products for veterinary use. These animal health products are targeted towards food-producing animals (cattle, pigs, poultry and sheep) and companion animals (primarily dogs and cats).
What's included in this industry?
Parasiticides Immunotherapy product and vaccinesAntibiotics and related productsNutrition and metabolism productsOther animal healthcare productsCompanies
Zoetis AustraliaMSD Animal HealthVirbac (Australia)Purchase this report to view all 5 major companies in this industry.
Related Terms
COMPANION ANIMALAGVET CHEMICALSZOONOTIC DISEASESIndustry Code
ANZSIC 1842 - Veterinary Pharmaceutical Manufacturing in Australia
Performance
Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.
Analyst insights
Seasonal weather conditions have weakened demand from livestock farmers. Yet, a surge in pet ownership and pet humanisation trends has supported an upswing in revenue.
In this chapter (4)
- Current Performance
- Outlook
- Volatility
- Life Cycle
Key metrics
- Annual Revenue, Recent Growth, Forecast, Revenue Volatility
- Number of Employees, Recent Growth, Forecast, Employees per Business, Revenue per Employee
- Number of Businesses, Recent Growth, Forecast, Employees per Business, Revenue per Business
- Total Profit, Profit Margin, Profit per Business
Charts
- Revenue, including historical (2014-2023) and forecast (2024-2029)
- Employees, including historical (2014-2023) and forecast (2024-2029)
- Businesses, including historical (2014-2023) and forecast (2024-2029)
- Profit, including historical (2014-2024)
- Industry Volatility vs. Revenue Growth
- Industry Life Cycle
Detailed analysis
- Trends in supply, demand and current events that are driving current industry performance
- Expected trends, economic factors and ongoing events that drive the industry's outlook
- Key success factors for businesses to overcome volatility
- How contribution to GDP, industry saturation, innovation, consolidation, and technology and systems influence the industry's life cycle phase.
Products and Markets
Learn about an industry's products and services, markets and trends in international trade.
Analyst insight
Parasiticides are the largest product segment for veterinary pharmaceutical manufacturers. Yet, sales have slid thanks to a rigorous approval process and strong regulations.
In this chapter
- Products & Services
- Major Markets
- International Trade
Key metrics
- Largest market segment and value in 2024
- Product innovation level
- Total imports, level and trend
- Total exports, level and trend
- Trade Balance
Charts
- Products & services segmentation in 2024
- Major market segmentation in 2024
- International trade, including imports by country and exports by country
Detailed analysis
- Trends impacting the recent performance of the industry's various segments
- Innovations in the industry's product or service offering, specialization or delivery method
- Key factors that successful businesses consider in their offerings
- Buying segments and key trends influencing demand for industry products and services
- Recent trends in import and export volumes, country of origin or destination, and expected future trends
Geographic Breakdown
Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.
Analyst insights
New South Wales, Victoria and Queensland dominate the veterinary pharmaceutical market based on the location of manufacturers. Access to shipping ports, airports and chemical...
In this chapter (1)
- Business Locations
Charts
- Share of revenue, establishment, wages and employment in each region
- Share of population compared to establishments in each region in 2024
Tables
- Number and share of establishments in each region in 2024
- Number and share of revenue each region accounts for in 2024
- Number and share of wages each region accounts for in 2024
- Number and share of employees in each region in 2024
Detailed analysis
- Geographic spread of the industry across Asia Pacific, and trends associated with changes in the business landscape
- Key success factors for businesses to use location to their advantage
Competitive Forces
Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.
Analyst insights
Economies of scale are a competitive advantage for veterinary pharmaceutical manufacturers. Being able to spread fixed and variable costs over a larger product base provides ...
In this chapter (4)
- Concentration
- Barriers to Entry
- Substitutes
- Buyer & Supplier Analysis
Key metrics
- Industry concentration level
- Industry competition level and trend
- Barriers to entry level and trend
- Substitutes level and trend
- Buyer power level and trend
- Supplier power level and trend
Charts
- Market share concentration among the top 4 suppliers from 2019-2024
- Supply chain including upstream supplying industries and downstream buying industries, flow chart
Detailed analysis
- Factors impacting the industry’s level of concentration, such as business distribution, new entrants, or merger and acquisition activity.
- Key success factors for businesses to manage the competitive environment of the industry.
- Challenges that potential industry entrants face such as legal, start-up costs, differentiation, labor/capital intensity and capital expenses.
- Key success factors for potential entrants to overcome barriers to entry.
- Competitive threats from potential substitutes for the industry’s own products and services.
- Key success factors for how successful businesses can compete with substitutes.
- Advantages that buyers have to keep favorable purchasing conditions.
- Advantages that suppliers have to maintain favorable selling conditions.
- Key success factors for how businesses can navigate buyer and supplier power.
Companies
Learn about the performance of the top companies in the industry.
Analyst insights
Subsidiaries of global corporations dominate veterinary pharmaceutical manufacturing. Collectively, the three largest manufacturers control over 90% of the domestic market.
In this chapter
- Market Share Concentration
- Companies
- Company Spotlights
Charts
- Industry market share by company in 2020 through 2024
- Major companies in the industry, including market share, revenue, profit and profit margin in 2024
- Overview of Zoetis Australia's performance by revenue, market share and profit margin from 2018 through 2024
- Overview of MSD Animal Health's performance by revenue, market share and profit margin from 2018 through 2024
- Overview of Virbac (Australia)'s performance by revenue, market share and profit margin from 2018 through 2024
- Overview of revenue, market share and profit margin trend for 2 additional companies
Detailed analysis
- Description and key data for Zoetis Australia, and factors influencing its performance in the industry
- Description and key data for MSD Animal Health, and factors influencing its performance in the industry
- Description and key data for Virbac (Australia), and factors influencing its performance in the industry
- Description, key data and performance trends for 2 additional companies
External Environment
Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.
Analyst insights
Veterinary pharmaceutical manufacturers must comply with the Agricultural and Veterinary Chemicals Code Act 1994. The aim of the act is to evaluate, register and control agri...
In this chapter
- External Drivers
- Regulation & Policy
- Assistance
Key metrics
- Regulation & policy level and trend
- Assistance level and trend
Charts
- Regulation & Policy historical data and forecast (2014-2029)
- Assistance historical data and forecast (2014-2029)
Detailed analysis
- Demographic and macroeconomic factors influencing the industry, including Regulation & Policy and Assistance
- Major types of regulations, regulatory bodies, industry standards or specific regulations impacting requirements for industry operators
- Key governmental and non-governmental groups or policies that may provide some relief for industry operators.
Financial Benchmarks
View average costs for industry operators and compare financial data against an industry's financial benchmarks over time.
Analyst insights
Veterinary pharmaceutical manufacturers have enjoyed a hike in profitability. Recent herd-building activity and stronger demand from downstream cattle farming have contribute...
In this chapter
- Cost Structure
- Financial Ratios
- Key Ratios
Key metrics
- Profit margin, and how it compares to the sector-wide margin
- Average wages, and how it compares to the sector-wide average wage
- Largest cost component as a percentage of revenue
- Industry average ratios for days' receivables, industry coverage and debt-to-net-worth ratio
Charts
- Average industry operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
- Average sector operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
- Investment vs. share of economy
Data tables
- Cash Flow & Debt Service Ratios (2014-2029)
- Revenue per Employee (2014-2029)
- Revenue per Enterprise (2014-2029)
- Employees per Establishment (2014-2029)
- Employees per Enterprise (2014-2029)
- Average Wage (2014-2029)
- Wages/Revenue (2014-2029)
- Establishments per Enterprise (2014-2029)
- IVA/Revenue (2014-2029)
- Imports/Demand (2014-2029)
- Exports/Revenue (2014-2029)
Detailed analysis
- Trends in the cost component for industry operators and their impact on industry costs and profitability
Key Statistics
Industry Data
Data Tables
Including values and annual change:
- Revenue (2014-2029)
- IVA (2014-2029)
- Establishments (2014-2029)
- Enterprises (2014-2029)
- Employment (2014-2029)
- Exports (2014-2029)
- Imports (2014-2029)
- Wages (2014-2029)
Methodology
How are IBISWorld reports created?
IBISWorld has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.
Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for IBISWorld readers. Finally, each report is reviewed by one of IBISWorld’s editors, who provide quality assurance to ensure accuracy and readability.
IBISWorld relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.
What data sources do IBISWorld analysts use?
Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.
Key data sources in Australia include:
- Australian Bureau of Statistics
- Australian Taxation Office
- Australian Securities & Investments Commission
Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.
These sources include:
- Industry and trade associations
- Industry federations or regulators
- Major industry players annual or quarterly filings
Finally, IBISWorld’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.
How does IBISWorld forecast its data?
IBISWorld’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.
IBISWorld prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.
Learn more about our methodology and data sourcing on the Help Center.
Frequently Asked Questions
Unlock comprehensive answers and precise data upon purchase. View purchase options.
What is the market size of the Veterinary Pharmaceutical Manufacturing industry in Australia in 2024?
The market size of the Veterinary Pharmaceutical Manufacturing industry in Australia is $1.0bn in 2024.
How many businesses are there in the Veterinary Pharmaceutical Manufacturing in Australia industry in 2024?
There are 98 businesses in the Veterinary Pharmaceutical Manufacturing industry in Australia, which has grown at a CAGR of 2.9 % between 2019 and 2024.
Has the Veterinary Pharmaceutical Manufacturing industry in Australia grown or declined over the past 5 years?
The market size of the Veterinary Pharmaceutical Manufacturing industry in Australia has been growing at a CAGR of 1.5 % between 2019 and 2024.
What is the forecast growth of the Veterinary Pharmaceutical Manufacturing industry in Australia over the next 5 years?
Over the next five years, the Veterinary Pharmaceutical Manufacturing industry in Australia is expected to grow.
What are the biggest companies in the Veterinary Pharmaceutical Manufacturing market in Australia?
The biggest companies operating in the Veterinary Pharmaceutical Manufacturing market in Australia are Zoetis Australia, MSD Animal Health and Virbac (Australia)
What does the Veterinary Pharmaceutical Manufacturing in Australia include?
Parasiticides and Immunotherapy product and vaccines are part of the Veterinary Pharmaceutical Manufacturing industry.
Which companies have the highest market share in the Veterinary Pharmaceutical Manufacturing in Australia?
The company holding the most market share in Australia is Zoetis Australia.
How competitive is the Veterinary Pharmaceutical Manufacturing industry in Australia?
The level of competition is high and increasing in the Veterinary Pharmaceutical Manufacturing industry in Australia.
